| 供货周期： | 一周 |
| 品牌： | |
| 规格： | 2mg |
| 货号： | K1292 |
| CAS号： |
| SKU:K1292 | M. Wt:397.42 | ||
| Formula:C21H23N3O5 | Solubility:No | ||
| Purity:>99% | Storage:2 years at -20 degrees centigrade | ||
| CAS No.:783355-60-2 | Synonyms:CRA-02478 | ||
| Chemical NameN/A | |||
| Description | PCI-24781 | |||||
|---|---|---|---|---|---|---|
| Targets | HDAC1 | HDAC2 | HDAC3 | HDAC6 | HDAC8 | |
| IC50 | 7 nM | 19 nM | 8.2 nM | 17 nM | 280 nM | |
| In vitro | PCI-24781 (CRA-024781) can inhibit HDAC1, HDAC2, HDAC3, HDAC6, HDAC8 and HDAC10 with Ki of 7 nM, 19 nM, 8.2 nM, 17 nM, 280 nM, 24 nM. PCI-24781 can inhibit multidrug-resistant sarcoma cell lines in dose-dependent accumulation of acetylated histone, p21 and poly(ADP-ribose)polymerase (PARP) cleavage products. PCI-24781 can inhibit sarcoma cell lines with IC50 of 0.43 to 2.7 nM. PCI-24781 reverses drug resistance in all four multidrug-resistant sarcoma cell lines. | |||||
| In vivo | PCI-24781 [50 mg/kg/day] and control solutions were administered to BK5.erbB2 mice for 4 weeks. Treatment of BK5.erbB2 mice with PCI-24781 for 1 month prevented 79% of GBCa cases from progression and showed a clinical effect in 47% of cases. Treatment with PCI-24781 resulted in decreased expression of Muc4, an intramembrane ligand for ErbB2, in BTC cells. PCI-24781 had more effects on growth inhibition of BTC cells than SAHA. PCI-24781 effectively inhibited the growth of gemcitabine-resistant cells. | |||||
| Clinical Trials | N/A | |||||
| Features | N/A | |||||
相关产品
重组人肌球蛋白轻链2(Recombinant Human MYL2)
重组大鼠抵抗素(Rat Resistin)
大鼠酸性磷酸酶(ACP)ELISA Kit
大鼠胆囊收缩素/缩胆囊素八肽(CCK-8)ELISA Kit
人瘦素(LEP)ELISA Kit
重组人半乳糖凝集素16/LGALS16 Human
重组人半乳糖凝集素8/Human LGALS8 His
重组人半乳糖凝集素3/Human LGALS3 His
重组人卵泡抑素/Human FST His
重组人β防御素118/DEFB118 Human
重组人心肌营养素1/CTF1 Human
特级新生牛血清（无支原体）
超级新生牛血清（无支原体）
优级胎牛血清（无支原体）
特级新生牛血清（无噬菌体低内毒素）
工商信息
信息已认证
联系方式
详细地址
关注
拨打电话
留言咨询
